Replies to post #1709 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

Tyzeka vs Baraclude US Scripts
vs Elapsed Time from Launch*

      Tyzeka Baraclude 
 Week NRx TRx  NRx TRx 
  23  101 254  171 395 
  22  125 270  140 335 
  21  123 265  177 379 
  20  120 268  119 274 
  19  102 225  122 254 
  18  115 286  149 317 
  17  n/a n/a  132 269 
  16   86 214  131 229 
  15   78 197  144 252 
  14   91 212  125 250 
  13   80 191  103 184 
  12   65 167   97 190 
  11   79 169  131 189 
  10   80 152  138 211 
   9   93 191   93 142 
   8   92 188   73 113 
   7   80 161   72  93 
   6   76 146   49  86 
   5   61 135   69  87 
   4   82 137   61  69 
   3   87 142   50  50 
   2   55  90   47  49 
   1   54 103   51  53

* Tyzeka’s effective launch date is deemed to be 3/16/07, the first week after the NVS/IDIX salesforce received FDA DDMAC approval for the Tyzeka marketing materials. Baraclude’s launch date is deemed to be 4/15/05, the first week script data were available. (Baraclude scripts c/o Jonathan Robinson.)

[keitern]

LOL, I can just see a round of predictive graphs coming!

[go seek]

the mid-aug (2005) sales data for Baraclude were relatively weak also.

see 8/19/2005 data

#msg-22076801

[DewDiligence]

Tyzeka scripts (c/o rkrw)

Date  NRx TRx NRx% TRx% 
 Aug24 101 280 4.8% 3.6% 
 Aug17 101 254 4.5% 3.3% 
 Aug10 125 270 5.4% 3.5% 
 Aug03 123 265 5.3% 3.4% 
 Jul27 120 268 5.3% 3.5% 
 Jul20 102 225 4.7% 3.0% 
 Jul13 115 286 5.0% 3.7% 
 Jun29  86 214 3.8% 2.8% 
 Jun22  78 197 3.6% 2.7% 
 Jun15  91 212 4.0% 2.8% 
 Jun08  80 191 3.5% 2.5% 
 Jun01  65 167 3.4% 2.5% 
 May25  79 169 3.6% 2.3% 
 May18  80 152 3.7% 2.2% 
 May11  93 191 4.4% 2.6% 
 May04  92 188 4.1% 2.5% 
 Apr27  80 161 3.6% 2.2% 
 Apr20  76 146 3.6% 2.1% 
 Apr13  61 135 2.9% 1.9% 
 Apr06  82 137 3.9% 1.9% 
 Mar30  87 142 3.9% 2.0% 
 Mar23  55  90 2.7% 1.3% 
 Mar16  54 103 2.4% 1.4%